Litcius/Paper detail

Effect of left ventricular ejection fraction on the prognostic impact of chronic total occlusion in a non-infarct-related artery in patients with acute myocardial infarction

Hiromasa Ito, Jun Masuda, Tairo Kurita, Mizuki Ida, Ayato Yamamoto, Akihiro Takasaki, Tetsushiro Takeuchi, Yuichi Sato, Takashi Omura, Toshiki Sawai, Takashi Tanigawa, Masaaki Ito, Kaoru Dohi

2021IJC Heart & Vasculature11 citationsDOIOpen Access PDF

Abstract

BACKGROUND: Chronic total occlusion (CTO) in a non-infarct-related artery (IRA) in patients with acute coronary syndrome (ACS) is associated with a poor prognosis. However, whether the prognostic impact of non-IRA CTO differs according to left ventricular ejection fraction (LVEF) is unclear. METHODS AND RESULTS: A total of 2060 consecutive acute myocardial infarction (AMI) patients who underwent primary percutaneous coronary intervention (PCI) were classified into 2 groups according to their LVEF (reduced EF: LVEF < 50%, preserved EF: LVEF ≥ 50%) and further subdivided according to the presence of concomitant non-IRA CTO. In the reduced EF group, patients with CTO had a higher 1-year all-cause death rate (20.3% vs. 34.3%, P = 0.001) and major adverse cardiac event rate (MACE: 19.6% vs. 39.6%, P < 0.001) compared to those without CTO, but they were similar between patients with and without CTO in the preserved EF group. Non-IRA CTO was an independent predictor of all-cause death (HR 1.58, 95% CI 1.06-2.33, P = 0.02) and MACE (HR 1.67, 95% CI 1.14-2.46, P = 0.009) only in the reduced EF group. In addition, the outcomes of successful CTO-PCI seemed to be similar to those without CTO in the reduced EF group. CONCLUSIONS: CTO in a non-IRA may contribute to a poor prognosis only in AMI patients with reduced LVEF.

Topics & Concepts

MedicineEjection fractionCardiologyInternal medicineMyocardial infarctionOcclusionInfarctionCoronary occlusionCoronary artery occlusionHeart failureAcute Myocardial Infarction ResearchCoronary Interventions and DiagnosticsCardiac Imaging and Diagnostics